Feng Xu

3.4k total citations
117 papers, 2.0k citations indexed

About

Feng Xu is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Feng Xu has authored 117 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 36 papers in Plant Science and 18 papers in Pharmacology. Recurrent topics in Feng Xu's work include Natural product bioactivities and synthesis (31 papers), Phytochemistry and Biological Activities (22 papers) and RNA and protein synthesis mechanisms (10 papers). Feng Xu is often cited by papers focused on Natural product bioactivities and synthesis (31 papers), Phytochemistry and Biological Activities (22 papers) and RNA and protein synthesis mechanisms (10 papers). Feng Xu collaborates with scholars based in China, United Kingdom and United States. Feng Xu's co-authors include Zihe Rao, Stephen G. Bell, Luet‐Lok Wong, Hongmei Wu, Xulong Huang, Xuehui Chen, Baowei Jiao, Li Zou, Haibo Xu and Limin Zhao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Feng Xu

111 papers receiving 1.9k citations

Peers

Countries citing papers authored by Feng Xu

Since Specialization

Citations

This map shows the geographic impact of Feng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Xu more than expected).

Fields of papers citing papers by Feng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Xu. The network helps show where Feng Xu may publish in the future.

Co-authorship network of co-authors of Feng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Xu. A scholar is included among the top collaborators of Feng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Xu. Feng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Angelica dahurica Polysaccharides Ameliorate Colitis by Reducing the Restriction of Gut Microbiota‐Derived Imidazole Propionate on PPAR‐γ Signaling Activation 2025 ·Phytotherapy Research ·Jingyi Hu, Feng Xu, Lei Zhu, Yuan Cui, (unknown), Yanan Li, Yiheng Tong, Hong Shen	1
2	Bi-allelic loss-of function variants in ATP2A1 cause autosomal recessive Brody disease 2025 ·QJM ·Chunyan Cao, (unknown), Feng Xu, (unknown), Wenqi Lv, Yao Xu, (unknown), (unknown), Min-Ting Lin, Ning Wang, Zhiqiang Wang, Jinpeng He, Jiewen Zhang, (unknown)	0
3	RRM1 promotes homologous recombination and radio/chemo-sensitivity via enhancing USP11 and E2F1-mediated RAD51AP1 transcription 2024 ·Cell Death Discovery ·Shuai Yang, Ruru Wang, Lingling Liu, Feng Xu, (unknown), (unknown), Jie Zhang, (unknown), An Xu, Lijun Wu, Guoping Zhao	2
4	Therapeutic Effects of Qingchang Tongluo Decoction on Intestinal Fibrosis in Crohn’s Disease: Network Pharmacology, Molecular Docking and Experiment Validation 2024 ·Drug Design Development and Therapy ·Yanan Li, Jingyi Hu, (unknown), Cheng Cheng, Feng Xu, (unknown), (unknown), (unknown), Lei Zhu, Hong Shen	5
5	LC-MS guided isolation of cytotoxic saponins from the flower buds of Lonicera macranthoides 2023 ·Phytochemistry Letters ·(unknown), (unknown), Guodong Zhang, (unknown), (unknown), (unknown), Feng Xu, Shan Yu, Yu Chen	2
6	Therapeutic effect of total flavonoids of Sargentodoxa cuneata on ulcerative colitis in mice by correcting gut dysbiosis 2023 ·Arabian Journal of Chemistry ·Feng Xu, (unknown), Hongmei Wu, (unknown), (unknown), Hongyun Liu, Qian Zeng, (unknown)	3
7	Screening compounds for treating the diabetes and COVID-19 from Miao medicine by molecular docking and bioinformatics 2023 ·Arabian Journal of Chemistry ·Feng Xu, Xulong Huang, Hongmei Wu, (unknown)	4
8	Anti-Ulcerative Colitis Effects and Active Ingredients in Ethyl Acetate Extract from Decoction of Sargentodoxa cuneata 2023 ·Molecules ·(unknown), Feng Xu, Hongmei Wu, (unknown), (unknown), Mei Zhang, (unknown), Ping Qin	5
9	Integrated Network Pharmacology, Molecular Docking and Animal Experiment to Explore the Efficacy and Potential Mechanism of Baiyu Decoction Against Ulcerative Colitis by Enema 2023 ·Drug Design Development and Therapy ·Yuan Cui, Jingyi Hu, Yanan Li, (unknown), (unknown), Cheng Cheng, Feng Xu, (unknown), (unknown), Lei Zhu, Hong Shen	5
10	Lupenone improves type 2 diabetic nephropathy by regulating NF-κB pathway-mediated inflammation and TGF-β1/Smad/CTGF-associated fibrosis 2023 ·Phytomedicine ·Hongmei Wu, Feng Xu, Xulong Huang, Xiaofen Li, (unknown), Lingling Zhang, Xiaosong Yang, Juan Kong, (unknown), (unknown)	12
11	Engineering the large pocket of an (S)-selective transaminase for asymmetric synthesis of (S)-1-amino-1-phenylpropane 2021 ·Catalysis Science & Technology ·(unknown), Feng Xu, Lin Yang, Liu He, Xiangyang Xu, Hualei Wang, Dongzhi Wei	11
12	Inhibitory Effects and Surface Plasmon Resonance-Based Binding Affinities of Dietary Hydrolyzable Tannins and Their Gut Microbial Metabolites on SARS-CoV-2 Main Protease 2021 ·Journal of Agricultural and Food Chemistry ·Huifang Li, Feng Xu, Chang Liu, (unknown), Joel A. Dain, Dongli Li, Navindra P. Seeram, Bongsup P. Cho, Hang Ma	22
13	The Study on the Active Ingredients and Potential Targets of Rice Bran Petroleum Ether Extracts for Treating Diabetes Based on Network Pharmacology 2020 ·Combinatorial Chemistry & High Throughput Screening ·Xulong Huang, (unknown), Hongmei Wu, (unknown), Feng Xu	3
14	A Network Pharmacology Approach to Identify Potential Molecular Targets for Cannabidiol's Anti-Inflammatory Activity 2020 ·Cannabis and Cannabinoid Research ·Hang Ma, Feng Xu, Chang Liu, Navindra P. Seeram	22
15	Tetramethylpyrazine attenuates oleic acid-induced acute lung injury/acute respiratory distress syndrome through the downregulation of nuclear factor-kappa B (NF- k B) activation in rats 2011 ·AFRICAN JOURNAL OF BIOTECHNOLOGY ·(unknown), Feng Xu, (unknown), (unknown), (unknown)	3
16	Triterpene glycosides from Lonicera. II. Isolation and structural determination of glycosides from flower buds of Lonicera macranthoides 2009 ·Chemistry of Natural Compounds ·Yu Chen, Feng Xu, Ming Wang, Xiaodong Jia, (unknown), (unknown)	24
17	Determination of Tulobuterol in Rabbit′s Plasma by LC/MS and Study of Its Pharmacokinetics 2005 ·Zhongguo yaoke daxue xuebao ·Feng Xu	1
18	Crystal Structure of Human Tryptophanyl-tRNA Synthetase Catalytic Fragment 2004 ·Journal of Biological Chemistry ·Yadong Yu, Yunqing Liu, Ning Shen, Xiang Xu, Feng Xu, Jie Jia, Youxin Jin, Eddy Arnold, Jianping Ding	39
19	HPLC Determination of Harpagoside and Cinnamic Acid in Radix Scrophulariae 2001 ·Journal of Chinese Pharmaceutical Sciences ·Lihua Xie, Hongyu Liu, (unknown), Xuan Wang, (unknown), Feng Xu, Shaoqing Cai	3
20	High-Level Expression and Single-Step Purification of Human Tryptophanyl-tRNA Synthetase 2001 ·Protein Expression and Purification ·Feng Xu, Jie Jia, Youxin Jin, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact